Medtronic SCS device restores function in SMA trial
The use of a spinal cord stimulation (SCS) device has the potential to gradually reawaken functionally silent motor neurons and …
The use of a spinal cord stimulation (SCS) device has the potential to gradually reawaken functionally silent motor neurons and …
As global supply chains come under increasing strain and AI disrupts how clinical trials are conducted, experts will congregate to …
US-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) and Health Canada for …
A US university has launched a prevention trial examining the use of Eli Lilly’s investigational remternetug in young adults to …
Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination of opaganib and darolutamide …
US-based pharmaceutical company Cumberland Pharmaceuticals has reported positive top-line outcomes from a Phase II trial of ifetroban as a potential …
Italian research charity Telethon Foundation is one step closer to getting a gene therapy to treat rare disease Wiskott-Aldrich syndrome …
Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures glucose levels from a …
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options …
PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal …
As the second most common neurodegenerative disorder, Parkinson's disease primarily impacts individuals over the age of 65. In 2019, more …
Immunotherapeutics have transformed the landscape of cancer outcomes. It is crucial that the atypical response patterns seen with them are …
A Sudan Ebola vaccine, provided by the International AIDS Vaccine Initiative (IAVI), is being investigated in a Uganda vaccine trial …
Nearly 70,000 women throughout the UK are set to take part in an AI-driven trial designed to advance methods of …
Entrada Therapeutics has secured authorisation from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to begin the randomised, two-part …